Carl Camras Translational Research Awards Grant

Carl Camras Translational Research Awards Grant

Status: ACTIVE
Funder: The Association for Research in Vision and Ophthalmology
Amount: US $12,000
Last Updated: October 14, 2025

Summary

The Carl Camras Translational Research Awards, established by the Association for Research in Vision and Ophthalmology (ARVO) in 2010, honors young researchers (45 and under) excelling in scientific discoveries related to glaucoma and other vision disorders. With a prize of $12,000, this award recognizes innovative concepts and technologies that promise clinical application, contributing to ARVO's mission of advancing global eye research.

Overview

The Association for Research in Vision and Ophthalmology ARVO is the largest eye and vision research organization in the world. The Association's membership today numbers about 12,000 and continues to grow. Some 40% of members reside in over 70 countries outside the U.S. The membership is multidisciplinary and consists of both clinical and basic researchers. Mission ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Carl Camras Translational Research Awards The award honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist. This award acknowledges young investigators, 45 years of age or younger, who have exhibited excellence in research and their fundamental scientific discoveries, concepts and novel technologies. Their discovery or observation must have led to, or have the promise of leading to, clinical application. An award of $12,000 will be presented. This award, which was established in 2010, is supported through the ARVO Foundation.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Eligible nominees include young researchers who are 45 years of age or less at the time of nomination. Eligible nominees will have exhibited excellence in research and their fundamental scientific discoveries, concepts and novel technologies. Their discovery or observation must have led to, or have the promise of leading to, clinical application.Other specific eligibility requirements for the nominee and the nominator include:Neither nominees nor nominators are required to be ARVO members.Nominators and seconders may only support one nomination and should not be from the same institution as the nominee.Nominations may be resubmitted for a future year if unsuccessful.

Ineligibility

Foundation and ARVO Officers, Board members and Awards Committee members are not eligible to nominate or be nominated for an award during their terms, or to offer seconding letters of support.Previous recipients of the Carl Camras Translational Research Awards are not eligible.Research that has possible translational implications at a later stage of development, such as snp polymorphisms associated with disease that have not yet lead to interventions, are not appropriate for this award.